Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/08 → 12/31/15 |
Funding
- Novartis (domestic): $358,355.00
A Phase II Study of Combined Fulvestrant (Fulvestrant) and RAD001 (Everolimus) in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
- Chambers, Mara (PI)
- Massarweh, Suleiman (Former PI)